Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.38.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-19060.5South Korea
DV.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-19060.5South Korea
B.1.639NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-19061.8South Korea
B.1.636NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-19061.8South Korea
B.1.1.377ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-19064.8Singapore
B.1.500NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-19067.8Germany
B.1.441NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-19068.5US
AY.30 (Delta)NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-19068.5US
GE.1.2.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-19068.5US
GE.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-19083.8Japan
B.1.530ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-19083.8Japan
AY.70 (Delta)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-19086China
XBB.1.16.5SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-19090.3Singapore
P.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19092.4South Korea
BA.2.73SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-19104China
B.1.1.466SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-19104China
BA.2.65SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-19104China
AS.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-19106.5South Korea
B.1.282SWon-SCTACATGCACCAGCAACTGT20502311423133F-19106.5South Korea
BF.25NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19109.8Hong Kong
BF.10NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19109.8Hong Kong
BF.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19109.8Hong Kong
BS.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19109.8Hong Kong
BN.1.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-19109.8Hong Kong
BA.2.76SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BS.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BM.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.3.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.51SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XATSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.85SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.65SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BG.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.61SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.74SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BM.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.13.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
N.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.407SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.423SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.281SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AE.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used